Skip to main content
Premium Trial:

Request an Annual Quote

Japanese Companies Invest $11M in SomaLogic for Asian Office, Array Collaboration

NEW YORK, Dec. 17 (GenomeWeb News) - Two Japanese companies have invested $11 million in SomaLogic, the company said today.


Mitsui & Co, an earlier investor in SomaLogic, has invested $10 million in the company, which will support the opening of a joint division of the companies in Asia, while plastics manufacturer Sumitomo Bakelite has invested $1 million, and will collaborate with SomaLogic to develop surfaces for the company's aptamer microarrays, SomaLogic said.


"The combined investments from Mitsui and Sumitomo Bakelite greatly advance our shared goal of commercializing SomaLogic's technology and establishing a presence in Asia," stated Dr. Larry Gold, SomaLogic's Chairman of the Board, Chief Scientific Officer and the inventor of aptamers. "As strong regional partners they will help us build the relationships critical to success in this region."


SomaLogic, of Boulder, Colorado, is developing protein microarrays using aptamers, single-stranded DNA and RNA molecules that specifically bind to target molecules with high affinity.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.